A recent meta-analysis revealed that vitamin D intervention improves FBG, HbA1c, insulin levels, and HOMA-IR in patients with T2DM, particularly among those with baseline vitamin D deficiency (39). This evidence concerns the gene INS and vitamin D deficiency.